310 related articles for article (PubMed ID: 23576270)
1. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer.
Champattanachai V; Netsirisawan P; Chaiyawat P; Phueaouan T; Charoenwattanasatien R; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J
Proteomics; 2013 Jul; 13(14):2088-99. PubMed ID: 23576270
[TBL] [Abstract][Full Text] [Related]
2. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
3. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
4. Global identification of O-GlcNAc transferase (OGT) interactors by a human proteome microarray and the construction of an OGT interactome.
Deng RP; He X; Guo SJ; Liu WF; Tao Y; Tao SC
Proteomics; 2014 May; 14(9):1020-30. PubMed ID: 24536041
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion.
Netsirisawan P; Chokchaichamnankit D; Srisomsap C; Svasti J; Champattanachai V
Cancer Genomics Proteomics; 2015; 12(4):201-9. PubMed ID: 26136220
[TBL] [Abstract][Full Text] [Related]
7. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
8. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
9. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.
Drougat L; Olivier-Van Stichelen S; Mortuaire M; Foulquier F; Lacoste AS; Michalski JC; Lefebvre T; Vercoutter-Edouart AS
Biochim Biophys Acta; 2012 Dec; 1820(12):1839-48. PubMed ID: 22967762
[TBL] [Abstract][Full Text] [Related]
10. Quantitative regulation of nuclear pore complex proteins by O-GlcNAcylation.
Mizuguchi-Hata C; Ogawa Y; Oka M; Yoneda Y
Biochim Biophys Acta; 2013 Dec; 1833(12):2682-2689. PubMed ID: 23777819
[TBL] [Abstract][Full Text] [Related]
11. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
[TBL] [Abstract][Full Text] [Related]
12. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
[TBL] [Abstract][Full Text] [Related]
13. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte.
Dehennaut V; Slomianny MC; Page A; Vercoutter-Edouart AS; Jessus C; Michalski JC; Vilain JP; Bodart JF; Lefebvre T
Mol Cell Proteomics; 2008 Nov; 7(11):2229-45. PubMed ID: 18617508
[TBL] [Abstract][Full Text] [Related]
14. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans.
Lee J; Kim KY; Lee J; Paik YK
J Biol Chem; 2010 Jan; 285(5):2930-9. PubMed ID: 19940149
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence of O-GlcNAcylation in the apicomplexan Toxoplasma gondii: a biochemical and bioinformatic study.
Perez-Cervera Y; Harichaux G; Schmidt J; Debierre-Grockiego F; Dehennaut V; Bieker U; Meurice E; Lefebvre T; Schwarz RT
Amino Acids; 2011 Mar; 40(3):847-56. PubMed ID: 20661758
[TBL] [Abstract][Full Text] [Related]
17. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.
Jochmann R; Pfannstiel J; Chudasama P; Kuhn E; Konrad A; Stürzl M
Glycobiology; 2013 Oct; 23(10):1114-30. PubMed ID: 23580777
[TBL] [Abstract][Full Text] [Related]
20. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
Dauphinee SM; Ma M; Too CK
J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
